STAHIST AD - 58407-625-30 - (CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE)

Alphabetical Index


Drug Information of STAHIST AD

Product NDC: 58407-625
Proprietary Name: STAHIST AD
Non Proprietary Name: CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE
Active Ingredient(s): 25; 60    mg/1; mg/1 & nbsp;   CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of STAHIST AD

Product NDC: 58407-625
Labeler Name: Magna Pharmaceuticals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20111220

Package Information of STAHIST AD

Package NDC: 58407-625-30
Package Description: 1 BOTTLE in 1 BOX (58407-625-30) > 30 TABLET in 1 BOTTLE

NDC Information of STAHIST AD

NDC Code 58407-625-30
Proprietary Name STAHIST AD
Package Description 1 BOTTLE in 1 BOX (58407-625-30) > 30 TABLET in 1 BOTTLE
Product NDC 58407-625
Product Type Name HUMAN OTC DRUG
Non Proprietary Name CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20111220
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Magna Pharmaceuticals, Inc.
Substance Name CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Strength Number 25; 60
Strength Unit mg/1; mg/1
Pharmaceutical Classes

Complete Information of STAHIST AD


General Information